Evident Vascular wins FDA 510(k) for AI-powered IVUS imaging platform
The clearance covers the Evident Vascular guidance system and peripheral imaging catheters for intravascular ultrasound in peripheral vascular interventions, with AI and hands-free voice control claimed by the company.
Why it matters
AI-assisted intravascular imaging is moving from research claims into cleared clinical tools for peripheral work. Evident’s 510(k) puts a purpose-built IVUS stack with claimed high-fidelity imaging and voice control onto the US market, competing with established ultrasound vendors. What to watch next is clinical uptake and whether peer-reviewed outcome data follow the clearance.
Key facts
- FDA 510(k) for guidance system and peripheral imaging catheters
- Intended for intravascular ultrasound in peripheral vascular interventions
- Company cites AI imaging, flushless plug-and-play catheters and voice control
- CEO Howard Rosen called clearance a milestone for physicians who backed the platform
- Reported by Vascular News on 6 Nov 2026 at 11:15 UTC